Study: Physicians give less credence to studies funded by pharmaceutical industry
By Chelsea Conaboy, Globe Staff
Doctors are less likely to trust studies funded by the pharmaceutical industry even when they are well-designed, a study lead by researchers at Brigham and Women’s Hospital and Harvard Medical School found.
Recent ethical transgressions in industry-funded studies likely have affected how physicians view industry research, the authors write. But pharmaceutical companies continue to play a big role in drug development.
Doctors should be wary, said Dr. Aaron Kesselheim, lead author on the study published in this week’s New England Journal of Medicine. “On the other hand,” he said, “there is a lot of good industry-funded research out there. If people are being too skeptical and painting everything with the same brush, then that will reduce the inclination for physicians to act on really good research simply because it’s being funded” by pharmaceutical companies.
The researchers evaluated the responses of 263 internists assessing a series of studies for hypothetical new drugs to treat persistent chest pain, diabetes, or high blood cholesterol. The physicians were asked to score the studies on how confident they were in the results and how likely they were to prescribe the drug.
The studies were of variable levels of quality. Some were characterized as large, randomized, long-running studies that included reports on a drug’s safety. Others were significantly smaller, with no safety report and no “blinding,” meaning patients and physicians knew whether they were in the study group or control group, which can bias the results.
The studies also had either no funding disclosure or were described as being funded by a pharmaceutical company or by the federal government’s National Institutes of Health.
Kesselheim said he was “heartened” to see how well the doctors distinguished between strong study designs and weaker ones. The ways in which they interpreted funding disclosures were trickier.
Doctors generally discounted the credibility they assigned to studies funded by industry, as compared with those that were government-funded or had no funding disclosure at all. That was true even when the strength of design was the same across the studies.
The authors note that a doctor’s willingness to prescribe a new drug may be determined in large part by a single significant study, so a physician’s perception ultimately can affect patient care.
Kesselheim said the results should put pressure on the pharmaceutical industry to prevent further ethical lapses. They highlight the need for more NIH funding of drug studies and continued efforts to monitor research to guard against results tampering, he said.
Chelsea Conaboy can be reached at cconaboy@boston.com. Follow her on Twitter @cconaboy.
http://www.boston.com/whitecoatnotes/2012/09/20/study-physicians-give-less-credence-studies-funded-pharmaceutical-industry/xd8MAnN5SqizUiBO6kTTOJ/story.html
GOTBO = glimpse of the bleeding obvious read more..
Wednesday, 3 October 2012
Chelsea Conaboy's GOTBO
Another 'must read'
A Must-Read Book That Exposes the Impact of Big Food, Big Ag and Big Pharma on Our Lives
Born with a Junk Food Deficiency: How flaks, quacks, and hacks pimp the public health
Martha Rosenberg
Prometheus Books
ISBN 978–1–61614–593–4
373 pages; Hardcover
Can anyone remember life before "Ask your Doctor" ads?—Born with a Junk Food Deficiency, p. 17
How can drugs designed to make animals gain weight fast not have an impact on national obesity?—Born with a Junk Food Deficiency, p. 219
Certain books are for certain people. Born with a Junk Food Deficiency is for people who eat, use prescription drugs, have or intend to have children, or care for or expect to care for aged parents. People who are concerned about women's health, veterans' health, animal welfare, consumer rights, truth-in-advertising, state or federal budget crises, or the undue influence of corporate money on democracy will want to read this book. Given that the food and pharmaceutical corporations that are mentioned in the book are transnational, I would also recommend it to anyone in the world who reads English.
Born with a Junk Food Deficiency is a thoroughly researched and documented exposé of what Big Food, Big Ag, and Big Pharma are doing to us, to animals, and to our ways of practicing business, medicine and democracy, all in the name of Big Profit. The author, independent investigative journalist Martha Rosenberg, told me in a telephone interview that she took seven years to do the research and another year to write and illustrate the book. What emerges from Rosenberg's research is a no-holds-barred indictment of corporate control over some of the most intimate aspects of our lives: The food we eat and the medicines, especially psychiatric medicines, we take.
Despite the title, the first part of Born with a Junk Food Deficiency is all about prescription drugs. The first chapter, "When the Medication is ready, the Disease (and Patients) will appear—OR when TV makes you sick," takes us on a journey through pharmaceutical advertising, starting in the '50s and '60s in professional journals such as the Journal of the American Medical Association (JAMA) through the current Direct-To-Consumer (DTC) advertising touting medications for every condition from seasonal allergies to bipolar disorder. She shows that these ads are heavily sexist and ageist and that in the effort to develop new markets, the pharmaceutical industry has developed a population that sees itself as ill. (According to About,com, nearly 4 billion prescriptions were written in the United States in 2010). People self-diagnose on websites, then report to their doctors demanding the latest advertised drug, sometimes with a coupon in hand. Rosenberg states in the book that doctors have had to take classes in refusal skills to deal with these patients.
Of course, sometimes people really do become ill, no thanks, in part, to our junk food diets. But the problem is not just too much soda and a sedentary lifestyle. Sometimes the problem is the chemicals with which Big Ag has laced our foods, especially our animal products, to make the most money in the shortest amount of time. A recent Agence France Press article, about the southern region of the U.S. being the most obese in the country, cast the blame on "cliché" Southern foods such as fried chicken and fried okra. As I pointed out to Rosenberg in our interview, these foods had been popular in the South long before the obesity epidemic. And as Rosenberg wrote in Chapter 9 of the book, titled The drugstore in your meat, " . . . [C]hickens were once slaughtered at 14 weeks old, when they weighed about two pounds, but by 2001, they were slaughtered at seven weeks, when they weighed between four and six pounds." (Hint: cooking does not rid the meat of growth-promoting hormones and antibiotics the animals are fed.)
For me, the best things about Born with a Junk Food Deficiency are the sometim read more..
Friday, 28 September 2012
Intone-Prweb
InControl Medical has certified Lora Plaskon, M.D., M.S., to prescribe InTone for women with bladder leakage.(PRWeb September 20, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9904655.htm (Source: PRWeb: Medical Pharmaceuticals) read more..
Shelba J. Bethel, M.D., Receives InTone Specialist Certification
InControl Medical has certified Shelba J. Bethel, M.D., to prescribe InTone for women with bladder leakage.(PRWeb September 22, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9906364.htm (Source: PRWeb: Medical Pharmaceuticals) read more..
Premature Ventricular-Chest Pains-Esperide-Intone-Facog
I am suffering from premature ventricular beats as well as premature atrial beats. Also getting short chest pains, This happens all day on and off and is definitely exercise induced. Cardiologist keeps on saying nothing to worry about. I lost my husband 4 months ago and have been on Esperide for about 6 months. I have suffered from arrythmias before when not on Esperide but nothing half as bad as at present. Could this be drug induced? I also take Zanor SR - 4 Replies read more..
Marko J. Jachtorowycz, MD, FACOG, FACS, Receives InTone Specialist...
InControl Medical has certified Marko J. Jachtorowycz, MD, FACOG, FACS, to prescribe InTone for women with bladder leakage.(PRWeb September 13, 2012)Read the full story at http://www.prweb.com/releases/2012/9/prweb9886889.htm (Source: PRWeb: Medical Pharmaceuticals) read more..
Monday, 24 September 2012
Ovarian Cancer Patients-European Union Group-Swiss Drug Maker-European Panel
Avastin, the world's best-selling cancer drug from Swiss drug maker Roche, received a positive opinion Friday from a European Union group to treat a subset of ovarian cancer patients.The Committee for Medicinal Products for Human Use, or CHMP, essentially recommended that EU authorities approve Avastin in combination with the chemotherapy agents carboplatin and gemcitabine to treat women with recurrent, platinum-sensitive ovarian cancer, the company said Friday.Avastin was developed by South… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..
Thursday, 20 September 2012
Misleading Advertising-Pharma Campaign
Got Low T? In one sense, it is refreshing to see men being the target of pharma, after all these years of women being the focus of relentless and misleading advertising. On the other, we re seeing the start of yet another pharma campaign to dupe the public by the unnecessary medicalization of symptoms to create new drug markets. I used to be a fairly enthusiastic pharma fan, but over recent years have become increasingly disillusioned. The hype over testosterone is the latest example of why. With so many pressing problems in the world, I wish pharma would focus their attention on doing something more useful with their energies. [More] (Source: Scientific American - Official RSS Feed)MedWorm Sponsor Message: Please have a look at this new site driven by MedWorm: The Breast Cancer Daily read more..
Saturday, 15 September 2012
Food Safety Modernization Act-Center For Food Safety-Regulations-Provisions-Fsma
By Ricardo Carvajal –The Center for Food Safety and the Center for Environmental Health filed suit in the Northern District of California to compel FDA and the Office of Management and Budget (“OMB”) to implement several major provisions of the Food Safety Modernization Act (“FSMA”). Those provisions require rulemaking to establish or provide for:
- Hazard analysis and risk-based preventive controls
- Clarification of activities that subject a farm to facility registration requirements
- Science-based minimum standards for the safe production and harvesting of fresh fruits and vegetables
- Protection against intentional adulteration
- Sanitary transportation of food
- Foreign supplier verification
- Standards for third-party audits
Plaintiffs cite the numerous outbreaks that have occurred since the passage of FSMA in support of their allegation that “the agency’s unlawful delay is putting millions of lives at risk from contracting foodborne illness.” They contend that FDA’s failure to issue the regulations and OMB’s failure to provide timely review “constitutes unlawfully withheld and unreasonably delayed agency action” within the meaning of the Administrative Procedure Act ("APA"). They also contend that FDA’s failure to enforce FSMA’s self-executing provisions constitutes an APA violation. Plaintiffs ask the court to order FDA to issue the regulations “as soon as reasonably practicable” pursuant to a court-ordered timeline, and to order OMB to approve the regulations and “cease interfering with FDA’s promulgation” of those regulations. Plaintiffs also ask the court to order FDA to “enforce all self-executing FSMA regulations immediately.”
The filing of this lawsuit comes as little surprise given the constituencies that backed passage of FSMA and the delays in the completion of OMB’s review. APA litigation to compel agency action is typically protracted, so we expect to follow this case for months (if not years) to come. read more..